HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCCAM Strategy Stresses Steps Toward Better Trials For Supplements

This article was originally published in The Tan Sheet

Executive Summary

The nutritional product industry expects benefits from the National Center for Complementary and Alternative Medicine draft strategic plan's emphasis on funding more preliminary research needed to launch informative clinical trials on supplement ingredients

You may also be interested in...



DHA Omega-3 Study Leaves Door Open For Role In Dementia Onset Prevention

Researchers conclude DHA fatty acid supplementation does not treat Alzheimer's disease, but they say the omega-3 substance may help prevent the onset of dementia.

CAM Survey May Boost Supplements Research

A National Center for Complementary and Alternative Medicine report on CAM spending could prompt more research into the health benefits consumers are increasingly seeking from dietary supplements and other products and services not considered part of conventional medicine

FDA Health Claims Draft Guidance Should Value Totality Of Evidence – CRN

FDA's apparent contention that results from randomized controlled trials invalidate conflicting information from observational studies on the effects of nutrients reflects "an intrinsic bias" within the agency or "a lack of fundamental understanding of research methods," according to the Council for Responsible Nutrition

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS134867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel